The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial
Title:
The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial
Author:
Gibson, C. Michael Halaby, Rim Korjian, Serge Daaboul, Yazan Arbetter, Douglas F. Yee, Megan K. Goldhaber, Samuel Z. Hull, Russel Hernandez, Adrian F. Lu, Shiao-ping Bandman, Olga Leeds, Janet M. Gold, Alex Harrington, Robert A. Cohen, Alexander T.